PORTABLE PNEUMOTACHOGRAPH FOR MEASURING COMPONENTS OF AN EXPIRATION VOLUME

• US 20160256072A1
• Filed: 05/17/2016
• Published: 09/08/2016
• Est. Priority Date: 06/05/2008
• Status: Active Application

• Current Assignee: Circassia AB
• Original Assignee: Aerocrine AB (Circassia Group Plc)
• Inventors: Eichler, Ruediger
• Application Number:
  US15/156,787
• Publication Number:
  US 20160256072A1
• Time in Patent Office: Days
• US Class Current: 1/1
• CPC Class Codes: A61B 5/082 Evaluation by breath analysis, e.g. determination of the chemical composition of exhaled breath A61B5/083, A61B5/091 take precedence
• CPC Class Codes: A61B 5/091 Measuring volume of inspired or expired gases, e.g. to determine lung capacity
• CPC Class Codes: A61B 5/097 Devices for facilitating collection of breath or for directing breath into or through measuring devices
• CPC Class Codes: A61B 5/145 Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissuemeasuring of blood pressure or blood flow A61B5/02; non-radiation detecting or locating of foreign bodies in blood A61B5/06
• CPC Class Codes: B01D 53/268 by diffusion

Abstract

A portable pneumotachograph for determining components in an exhalation volume. The problem of extreme sensitivity of sensors to temperature and moisture content of the gases, and cross-sensitivities to other potential components of the exhalation gas, is solved by providing a climate control chamber wherein a defined gas atmosphere can be set such that by means of the climate control chamber the relative humidity and/or temperature and/or composition of a sample and/or calibration gas can be set to predefined parameters.

Claims

1. A nitric oxide (NO) analyzer device that measures an NO level in a sample of an expiration volume from a patient, comprising:

a processor;

a pneumotachograph tube having a duct and comprising;

a mouth piece through which the expiration volume from the patient is received and enters the duct; and

a positive end-expiratory pressure (PEEP) valve that establishes an expiration resistance by limiting expiration flow from the patient into the pneumotachograph tube when pressure in the duct is less than a first threshold and opening to allow expiration flow into the duct when pressure in the duct exceeds the first threshold;

an NO measuring assembly coupled to the pneumotachograph tube and that detects the NO level in the sample, the sample taken from the expiration volume present in the duct, the NO sensor assembly controlled by the processor to measure the NO level at a point in time to correspond to exhalation from a zone of a respiratory tract of the patient to determine a location in the respiratory tract affected by disease.

2. The NO analyzer device of claim 1, wherein the PEEP valve limits expiration flow from the patient into the pneumotachograph tube when pressure in the duct is greater than a second threshold by closing when pressure in the duct exceeds the second threshold, the second threshold higher than the first threshold.

3. The NO analyzer device of claim 1, wherein the pneumotachograph tube further comprises an inlet through which air is drawn into the duct and then through the mouthpiece during inhalation of the patient.

4. The NO analyzer device of claim 3, further comprising a filter at the inlet, wherein the filter removes NO from air drawn into the duct during inhalation.

5. The NO analyzer device of claim 1, wherein the NO measuring assembly comprises an NO sensor.

6. The NO analyzer device of claim 5, wherein the NO measuring assembly further comprises a pump that moves the sample of the expiration volume past the NO sensor.

7. The NO analyzer device of claim 5, wherein the NO measuring assembly further comprises a sample conditioning assembly interposed between the NO sensor and the pneumotachograph tube, the sample conditioning assembly regulating at least one of temperature or humidity of the sample of the expiration volume.

8. The NO analyzer device of claim 7, the sample conditioning assembly comprising a climate control chamber and a conditioning hose through which the sample passes, the conditioning hose enclosed in the climate control chamber and the climate control chamber having a defined gas atmosphere surrounding the conditioning hose, the sample equalizing in at least one of temperature or humidity to a temperature or humidity of the defined gas atmosphere during passage through the conditioning hose.

9. The NO analyzer device of claim 7, wherein the NO measuring assembly further comprises a valve interposed between the conditioning assembly and the pneumotachograph tube, the valve opening to inflow of a calibration gas to feed the calibration gas to the NO sensor during a calibration routine of the NO analyzer device.

10. A method of determining location of disease in a respiratory tract of a patient, the method carried out by a nitric oxide (NO) analyzer and comprising:

receiving, via a mouth piece of a pneumotachograph tube of the NO analyzer, an expiration volume from the patient, the expiration volume flowing into a duct of the pneumotachograph tube under control of a positive end-expiratory pressure (PEEP) valve of the pneumotachograph tube, control by the PEEP valve comprising;

establishing an expiration resistance by limiting expiration flow from the patient into the pneumotachograph tube when pressure in the duct is less than a first threshold; and

allowing expiration flow into the duct when pressure exceeds the first threshold; and

measuring, with an NO measuring assembly of the NO analyzer, an NO level in a sample of the expiration volume, the sample taken from the expiration volume present in the duct, the measuring controlled to measure the NO level at a point in time that corresponds to exhalation from a zone of the respiratory tract of the patient to determine the location in the respiratory tract affected by disease.

11. The method of claim 10, wherein the control by the PEEP valve further includes limiting expiration flow from the patient into the pneumotachograph tube when pressure in the duct is greater than a second threshold by closing when pressure in the duct exceeds the second threshold, the second threshold higher than the first threshold.

12. The method of claim 10, further comprising passing air through the pneumotachograph tube that is drawn into the duct via an inlet during inhalation of the patient through the mouthpiece.

13. The method of claim 12, further comprising filtering the air drawn into the duct during inhalation to remove NO from the air.

14. The method of claim 10, wherein the NO measuring assembly includes an NO sensor.

15. The method of claim 14, further comprising pumping the sample of the expiration volume past the NO sensor.

16. The method of claim 14, further comprising conditioning the sample of the expiration volume between the NO sensor and the pneumotachograph tube, the conditioning comprising regulating at least one of temperature or humidity of the sample of the expiration volume.

17. The method of claim 16, the regulating including passing the sample of the expiration volume through a conditioning hose that is enclosed in a climate control chamber, the climate control chamber having a defined gas atmosphere surrounding the conditioning hose, the sample equalizing in at least one of temperature or humidity to a temperature or humidity of the defined gas atmosphere during passage through the conditioning hose.

18. The method of claim 16, further comprising calibrating the NO sensor including regulating at least one of temperature or humidity of a calibration gas and feeding the regulated calibration gas to the NO sensor.